Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:class |
WHO ATC system
|
| gptkbp:codePrefix |
N04
|
| gptkbp:hasSubgroup |
gptkb:N04B_(Dopaminergic_agents)
N04A (Anticholinergic agents) N04C (Monoamine oxidase B inhibitors) N04D (Other anti-Parkinson drugs) |
| gptkbp:partOf |
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
| gptkbp:subclassOf |
N Nervous system
|
| gptkbp:usedFor |
gptkb:Parkinson's_disease
|
| gptkbp:bfsParent |
gptkb:N04B
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
N04 (Anti-Parkinson drugs)
|